The latitude gradient for multiple sclerosis prevalence is established in the early life course.

Sabel, Clive E; Pearson, John F; Mason, Deborah F; Willoughby, Ernest; Abernethy, David A; Taylor, Bruce V

Sabel, Clive E; Pearson, John F; Mason, Deborah F; Willoughby, Ernest; Abernethy, David A; Taylor, Bruce V.

Afiliação

Sabel CE; BERTHA, Big Data Centre for Environment and Health, Department of Environmental Science, Aarhus University, Aarhus, Denmark.
Pearson JF; Biostatistics and Computational Biology Unit, University of Otago, Christchurch, New Zealand.
Mason DF; Christchurch Hospital, Christchurch, New Zealand.
Willoughby E; Auckland City Hospital, Auckland, New Zealand.
Abernethy DA; Capital and Coast Hospital, Wellington, New Zealand.
Taylor BV; Menzies Institute for Medical Research, University of Tasmania, Tasmania, Australia.

Brain ; 144(7): 2038-2046, 2021 08 17.

Article em En | MEDLINE | ID: mdl-33704407

Assuntos

Esclerose Múltipla/epidemiologia; Feminino; Geografia; Humanos; Masculino; Nova Zelândia/epidemiologia; Prevalência; Fatores de Risco

Palavras-chave

New Zealand; early life exposome; latitude gradient; multiple sclerosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Etiology_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Male País como assunto: Oceania Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google